(Press-News.org) Sustainable business innovation is good business; researchers from Aalto University, Finland have proved. The researchers tested how sustainability business innovations and the market value of companies in the construction sector are connected. The study is a first of its kind. An event study model was used to analyse large construction sector companies in several European countries as well as Australia.
The most important finding of the study is that a positive and statistically significant association exists between sustainability innovation announcements and the market value of companies.
When sustainability innovation announcements are reported regularly it explains an increase of 0.82% in the market capitalisation of the studied companies. Sustainability innovation announcements can be for example about renewable power solutions, sustainable workplace concept and carbon audit software.
Investments on sustainable practices by companies lead to the creation of economic value. The results imply that sustainability innovations can be relevant to the top management of companies operating in the business development. On top of that, information on sustainability innovations can also be useful to stock market investors when they evaluate the future growth potential of companies, says Professor Seppo Junnila from Aalto University, Finland.
INFORMATION:
Aalto University, Finland is a new multidisciplinary science and art community in the fields of science, economics, and art and design. The University is founded on Finnish strengths, and its goal is to develop as a unique entity to become one of the world's top universities. Aalto University's cornerstones are its strengths in education and research. At the new University, there are 20,000 basic degree and graduate students as well as a staff of 5,000 of which 350 are professors.
Sustainable business innovation adds firms' market value
2012-12-05
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Creativity and linguistic skills important for immersion in World of Warcraft
2012-12-05
The sense of immersion in role-play and computer games is sometimes viewed as dangerous, as players' strong perceptions of fictional worlds are assumed to make them lose contact with reality. On the other hand, players' immersion also implies a potential for improved learning, since it enables them to 'experience' new places and historical eras. Yet a new study from the University of Gothenburg, Sweden, shows that immersion in online role-play games requires a lot of hard work.
Gaming researcher Jonas Linderoth, at the Department of Education, Communication and Learning, ...
Adult antiviral drug effective in suppressing hepatitis B in teens
2012-12-05
A recent clinical trial found that the adult antiviral drug, tenofovir disoproxil fumarate (tenofovir DF), is safe and effective in treating adolescents with hepatitis B virus (HBV). Trial results published in the December issue of Hepatology, a journal of the American Association for the Study of Liver Diseases (AASLD), show that tenofovir DF suppressed HBV in 89% of pediatric participants.
Chronic HBV is a major health burden that studies estimate affects 350 million people worldwide, with 600,000 deaths attributed to this chronic disease. The Centers for Disease Control ...
In US first, Johns Hopkins surgeons implant brain 'pacemaker' for Alzheimer's disease
2012-12-05
Researchers at Johns Hopkins Medicine in November surgically implanted a pacemaker-like device into the brain of a patient in the early stages of Alzheimer's disease, the first such operation in the United States. The device, which provides deep brain stimulation and has been used in thousands of people with Parkinson's disease, is seen as a possible means of boosting memory and reversing cognitive decline.
The surgery is part of a federally funded, multicenter clinical trial marking a new direction in clinical research designed to slow or halt the ravages of the disease, ...
Reading history through genetics
2012-12-05
New York, NY—December 5, 2012—Computer scientists at Columbia's School of Engineering and Applied Science have published a study in the November 2012 issue of The American Journal of Human Genetics (AJHG) that demonstrates a new approach used to analyze genetic data to learn more about the history of populations. The authors are the first to develop a method that can describe in detail events in recent history, over the past 2,000 years. They demonstrate this method in two populations, the Ashkenazi Jews and the Masai people of Kenya, who represent two kinds of histories ...
Large pores
2012-12-05
This press release is available in German.
Researchers of the KIT Institute of Functional Interfaces (IFG), Jacobs University Bremen, and other institutions have developed a new method to produce metal-organic frameworks (MOFs). By means of the so-called liquid-phase epitaxy, the scientists succeeded in producing a new class of MOFs with a pore size never reached before. These frameworks open up interesting applications in medicine, optics, and photonics. The new class of MOFs, called "SURMOF 2", is presented in the "Nature Scientific Reports" journal.
Metal-organic ...
Pokemon provides rare opening for IU study of face-recognition processes
2012-12-05
BLOOMINGTON, Ind. -- At a Bloomington, Ind., toy store, kids ages 8 to 12 gather weekly to trade Pokemon cards and share their mutual absorption in the intrigue and adventure of Pokemon.
This may seem an unlikely source of material to test theories in cognitive neuroscience. But that is where Indiana University brain scientists Karin Harman James and Tom James were when an idea took hold.
"We were down at the club with our son, watching the way the kids talked about the cards, and noticed it was bigger than just a trading game," Tom James said.
Pokemon has since ...
'Resistance' to low-dose aspirin therapy extremely rare
2012-12-05
PHILADELPHIA — Roughly one-fifth of Americans take low-dose aspirin every day for heart-healthy benefits. But, based on either urine or blood tests of how aspirin blocks the stickiness of platelets – blood cells that clump together in the first stages of forming harmful clots – up to one third of patients are deemed unlikely to benefit from daily use. Such patients are called "aspirin resistant." Clots are the main cause of most heart attacks and strokes.
In people who have suffered a heart attack, low-dose aspirin reduces the chances of a second event by about one fifth, ...
RI Hospital: Standardized road test results differ from older adults' natural driving
2012-12-05
PROVIDENCE, R.I. – If you're thinking that little old lady driving 35 miles per hour in the passing lane shouldn't be behind the wheel, you may be right. Studies at Rhode Island Hospital, and elsewhere, have shown that our driving abilities decline with age, and for those with cognitive issues such as dementia, it can be even worse.
A standardized road test – much like the one teenagers take to receive their learner's permit and driver's license – is often used to measure an individual's performance, including those of older adults. But researchers at the Rhode Island ...
New test adds to scientists' understanding of Earth's history, resources
2012-12-05
GAINESVILLE, Fla. — A new study co-authored by a University of Florida researcher provides the first direct chronological test of sequence stratigraphy, a powerful tool for exploring Earth's natural resources.
The model allows geologists to better understand how sedimentary rocks are related to one another in time and space and predict what types of rocks are located in different areas. The information may help scientists more reliably interpret various aspects of Earth's history such as long-term climate changes or extinction events, and also benefit companies searching ...
Studying marrow, URMC researchers accelerate blood stem cells
2012-12-05
University of Rochester Medical Center scientists are testing a new approach to speed a patient's recovery of blood counts during a vulnerable period after a stem-cell transplant, according to a study published in the journal Stem Cells.
Laura M. Calvi, M.D., and Rebecca L. Porter, an M.D./Ph.D. student in Calvi's lab, reported that prostaglandin E2 (PGE2), a drug previously used to treat stomach ulcers, boosts blood production following an assault on the bone marrow from radiation or chemotherapy. Although their study was done in mice, Calvi believes it has significance ...